{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:12:02Z","timestamp":1778490722335,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-2-2047"],"award-info":[{"award-number":["2020-2-2047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04314-w","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:57:17Z","timestamp":1778489837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of long-term visual outcomes after tumor debulking in children with sporadic optic pathway glioma"],"prefix":"10.1007","volume":"49","author":[{"given":"Jiahao","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongji","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/cns.12.47","volume":"2","author":"I Fried","year":"2013","unstructured":"Fried I, Tabori U, Tihan T et al (2013) Optic pathway gliomas: a review. CNS Oncol 2:143\u2013159. https:\/\/doi.org\/10.2217\/cns.12.47","journal-title":"CNS Oncol"},{"key":"4314_CR2","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning MJ, Liu JK, Kestle JRW et al (2007) Optic pathway gliomas: a review. FOC 23:E2. https:\/\/doi.org\/10.3171\/FOC-07\/11\/E2","journal-title":"FOC"},{"key":"4314_CR3","first-page":"1963","volume":"22","author":"L Kornreich","year":"2001","unstructured":"Kornreich L, Blaser S, Schwarz M et al (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 22:1963\u20131969","journal-title":"AJNR Am J Neuroradiol"},{"key":"4314_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","volume":"81","author":"T Taylor","year":"2008","unstructured":"Taylor T, Jaspan T, Milano G et al (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. BJR 81:761\u2013766. https:\/\/doi.org\/10.1259\/bjr\/65246351","journal-title":"BJR"},{"key":"4314_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","volume":"132","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hwang EI, Jakacki RI, Packer RJ (2014) Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab. JAMA Ophthalmol 132:111. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5819","journal-title":"JAMA Ophthalmol"},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/nop\/npz076","volume":"7","author":"VM Lu","year":"2020","unstructured":"Lu VM, Welby JP, Nesvick CL, Daniels DJ (2020) Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates. Neuro-Oncology Pract 7:359\u2013368. https:\/\/doi.org\/10.1093\/nop\/npz076","journal-title":"Neuro-Oncology Pract"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cam4.1799","volume":"8","author":"N Zhukova","year":"2019","unstructured":"Zhukova N, Rajagopal R, Lam A et al (2019) Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma. Cancer Med 8:40\u201350. https:\/\/doi.org\/10.1002\/cam4.1799","journal-title":"Cancer Med"},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3171\/2019.2.PEDS18529","volume":"24","author":"ET Hidalgo","year":"2019","unstructured":"Hidalgo ET, Kvint S, Orillac C et al (2019) Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic\/pilomyxoid optic pathway gliomas. J Neurosurgery: Pediatr 24:166\u2013173. https:\/\/doi.org\/10.3171\/2019.2.PEDS18529","journal-title":"J Neurosurgery: Pediatr"},{"key":"4314_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3171\/jns.1990.73.5.0661","volume":"73","author":"JH Wisoff","year":"1990","unstructured":"Wisoff JH, Abbott R, Epstein F (1990) Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73:661\u2013667. https:\/\/doi.org\/10.3171\/jns.1990.73.5.0661","journal-title":"J Neurosurg"},{"key":"4314_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/neuonc\/noaa153","volume":"23","author":"AA Azizi","year":"2021","unstructured":"Azizi AA, Walker DA, Liu J-F et al (2021) NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat. Neurooncology 23:100\u2013111. https:\/\/doi.org\/10.1093\/neuonc\/noaa153","journal-title":"Neurooncology"},{"key":"4314_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0883073817739509","volume":"33","author":"CJ Campen","year":"2018","unstructured":"Campen CJ, Gutmann DH (2018) Optic Pathway Gliomas in Neurofibromatosis Type 1. J Child Neurol 33:73\u201381. https:\/\/doi.org\/10.1177\/0883073817739509","journal-title":"J Child Neurol"},{"key":"4314_CR12","doi-asserted-by":"publisher","unstructured":"Fisher MJ, Avery RA, Allen JC et al (2013) Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology 81. https:\/\/doi.org\/10.1212\/01.wnl.0000435745.95155.b8","DOI":"10.1212\/01.wnl.0000435745.95155.b8"},{"key":"4314_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0042-6989(97)88335-6","volume":"38","author":"C Mash","year":"1998","unstructured":"Mash C, Dobson V (1998) Long-term reliability and predictive validity of the teller acuity card procedure. Vision Res 38:619\u2013626. https:\/\/doi.org\/10.1016\/S0042-6989(97)88335-6","journal-title":"Vision Res"},{"key":"4314_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bjophthalmol-2017-311305","volume":"102","author":"K Falzon","year":"2018","unstructured":"Falzon K, Drimtzias E, Picton S, Simmons I (2018) Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Br J Ophthalmol 102:1367\u20131371. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311305","journal-title":"Br J Ophthalmol"},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge","year":"1958","unstructured":"Dodge HW (1958) Gliomas of the Optic Nerves. Arch NeurPsych 79:607. https:\/\/doi.org\/10.1001\/archneurpsyc.1958.02340060003001","journal-title":"Arch NeurPsych"},{"key":"4314_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13052-022-01316-4","volume":"48","author":"S Trapani","year":"2022","unstructured":"Trapani S, Bortone B, Bianconi M et al (2022) Diencephalic syndrome in childhood, a challenging cause of failure to thrive: miniseries and literature review. Ital J Pediatr 48:147. https:\/\/doi.org\/10.1186\/s13052-022-01316-4","journal-title":"Ital J Pediatr"},{"key":"4314_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4314_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1586\/14737140.7.11.1591","volume":"7","author":"L Massimi","year":"2007","unstructured":"Massimi L, Tufo T, Di Rocco C (2007) Management of optic\u2013hypothalamic gliomas in children: still a challenging problem. Expert Rev Anticancer Ther 7:1591\u20131610. https:\/\/doi.org\/10.1586\/14737140.7.11.1591","journal-title":"Expert Rev Anticancer Ther"},{"key":"4314_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","volume":"127","author":"R Listernick","year":"1995","unstructured":"Listernick R, Darling C, Greenwald M et al (1995) Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 127:718\u2013722. https:\/\/doi.org\/10.1016\/S0022-3476(95)70159-1","journal-title":"J Pediatr"},{"key":"4314_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/pbc.20655","volume":"46","author":"CD Jahraus","year":"2006","unstructured":"Jahraus CD, Tarbell NJ (2006) Optic pathway gliomas. Pediatr Blood Cancer 46:586\u2013596. https:\/\/doi.org\/10.1002\/pbc.20655","journal-title":"Pediatr Blood Cancer"},{"key":"4314_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fneur.2020.00766","volume":"11","author":"C Liao","year":"2020","unstructured":"Liao C, Zhang H, Liu Z et al (2020) The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic\u2013Hypothalamic Glioma Patients Who Received Surgery. Front Neurol 11:766. https:\/\/doi.org\/10.3389\/fneur.2020.00766","journal-title":"Front Neurol"},{"key":"4314_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ncpneuro0634","volume":"3","author":"N Pouratian","year":"2007","unstructured":"Pouratian N, Asthagiri A, Jagannathan J et al (2007) Surgery Insight: the role of surgery in the management of low-grade gliomas. Nat Rev Neurol 3:628\u2013639. https:\/\/doi.org\/10.1038\/ncpneuro0634","journal-title":"Nat Rev Neurol"},{"key":"4314_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2013.8.PEDS12546","volume":"13","author":"J Goodden","year":"2014","unstructured":"Goodden J, Pizer B, Pettorini B et al (2014) The role of surgery in optic pathway\/hypothalamic gliomas in children: Clinical article. PED 13:1\u201312. https:\/\/doi.org\/10.3171\/2013.8.PEDS12546","journal-title":"PED"},{"key":"4314_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijrobp.2011.10.067","volume":"84","author":"RM Awdeh","year":"2012","unstructured":"Awdeh RM, Kiehna EN, Drewry RD et al (2012) Visual Outcomes in Pediatric Optic Pathway Glioma After Conformal Radiation Therapy. Int J Radiation Oncology*Biology*Physics 84:46\u201351. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.067","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"4314_CR25","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH et al (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neurooncology 14:790\u2013797. https:\/\/doi.org\/10.1093\/neuonc\/nos076","journal-title":"Neurooncology"},{"key":"4314_CR26","doi-asserted-by":"publisher","first-page":"i145","DOI":"10.1093\/neuonc\/noy059.522","volume":"20","author":"M Bornhorst","year":"2018","unstructured":"Bornhorst M, Jecrois E, Mugayo DK, THERAPEUTIC TIME WINDOW THAT IMPROVES VISION IN AN NF1-DEFICIENT OPTIC PATHWAY GLIOMA MOUSE MODEL (2018) NFM-14. IDENTIFICATION OF A. Neurooncology 20:i145\u2013i145. https:\/\/doi.org\/10.1093\/neuonc\/noy059.522","journal-title":"Neurooncology"},{"key":"4314_CR27","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/cncr.33497","volume":"127","author":"AN Hanania","year":"2021","unstructured":"Hanania AN, Paulino AC, Ludmir EB et al (2021) Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer 127:2358\u20132367. https:\/\/doi.org\/10.1002\/cncr.33497","journal-title":"Cancer"},{"key":"4314_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.wneu.2022.04.033","volume":"164","author":"NA Shlobin","year":"2022","unstructured":"Shlobin NA, Montgomery EY, Mohammad LM et al (2022) Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review. World Neurosurg 164:436\u2013449e2. https:\/\/doi.org\/10.1016\/j.wneu.2022.04.033","journal-title":"World Neurosurg"},{"key":"4314_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-012-0944-y","volume":"110","author":"RA Avery","year":"2012","unstructured":"Avery RA, Ferner RE, Listernick R et al (2012) Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. J Neurooncol 110:1\u20137. https:\/\/doi.org\/10.1007\/s11060-012-0944-y","journal-title":"J Neurooncol"},{"key":"4314_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","volume":"30","author":"MK Farazdaghi","year":"2019","unstructured":"Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30:356\u2013363. https:\/\/doi.org\/10.1097\/ICU.0000000000000587","journal-title":"Curr Opin Ophthalmol"},{"key":"4314_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1227\/00006123-198205000-00001","volume":"10","author":"MLJ Apuzzo","year":"1982","unstructured":"Apuzzo MLJ, Chikovani OK, Gott PS et al (1982) Transcallosal, Interfornicial Approaches for Lesions Affecting the Third Ventricle. Neurosurgery 10:547\u2013554. https:\/\/doi.org\/10.1227\/00006123-198205000-00001","journal-title":"Neurosurgery"},{"key":"4314_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/00006123-199705000-00020","volume":"40","author":"PA Winkler","year":"1997","unstructured":"Winkler PA, Weis S, B\u00fcttner A et al (1997) The Transcallosal Interforniceal Approach to the Third Ventricle: Anatomic and Microsurgical Aspects. Neurosurgery 40:973\u2013982. https:\/\/doi.org\/10.1097\/00006123-199705000-00020","journal-title":"Neurosurgery"},{"key":"4314_CR33","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","volume":"389","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Hansford JR, Garr\u00e8 ML et al (2023) Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 389:1108\u20131120. https:\/\/doi.org\/10.1056\/NEJMoa2303815","journal-title":"N Engl J Med"},{"key":"4314_CR34","doi-asserted-by":"publisher","first-page":"e28833","DOI":"10.1002\/pbc.28833","volume":"68","author":"NJ Ullrich","year":"2021","unstructured":"Ullrich NJ, Prabhu SP, Packer RJ et al (2021) Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children. Pediatr Blood Cancer 68:e28833. https:\/\/doi.org\/10.1002\/pbc.28833","journal-title":"Pediatr Blood Cancer"},{"key":"4314_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/iovs.65.6.8","volume":"65","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yu J, Ge S et al (2024) An overview of optic pathway glioma with neurofibromatosis type 1: Pathogenesis, risk factors, and therapeutic strategies. Invest Ophthalmol Vis Sci 65:8. https:\/\/doi.org\/10.1167\/iovs.65.6.8","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04314-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:57:17Z","timestamp":1778489837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04314-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04314-w","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical data used in this study were reviewed and approved by the Institutional Review Board, and the study protocol was approved by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (approval No. KY2020-054-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study, as well as from their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This manuscript does not contain any individual personal data, images, or videos in any form. Consent for the use of anonymized information was obtained from the parents or legal guardians of the pediatric participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"not applicable. This study is a retrospective cohort study and does not require clinical trial registration.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}